Holen Sie sich die Stockscreener-App
7.22
0.70%
0.05
Vorhandelsmarkt:
7.26
0.04
+0.55%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.17
Offen:
$7.19
24-Stunden-Volumen:
5.79M
Relative Volume:
0.72
Marktkapitalisierung:
$1.17B
Einnahmen:
$847.25M
Nettoeinkommen (Verlust:
$-284.86M
KGV:
-3.1528
EPS:
-2.29
Netto-Cashflow:
$-112.35M
1W Leistung:
+4.94%
1M Leistung:
+12.64%
6M Leistung:
-18.23%
1J Leistung:
-51.67%
1-Tages-Spanne:
$6.925
$7.2398
1-Wochen-Bereich:
$6.8439
$7.2398
52-Wochen-Spanne:
$5.01
$17.81
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.22 | 1.11B | 847.25M | -284.86M | -112.35M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
What drives Novavax Inc. stock priceExceptional market positioning - Autocar Professional
Is Novavax Inc. a good long term investmentOutstanding capital appreciation - jammulinksnews.com
Novavax (NVAX) Price Target Lowered by B of A Securities | NVAX Stock News - GuruFocus
Novavax Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com
What analysts say about Novavax Inc. stockMarket-leading capital gains - Autocar Professional
Chief Strategist O’Hara On Novavax’s Partnership-Focused Approach - insights.citeline.com
(NVAX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT - MSN
Novavax’s Latest Vaccine Study: Key Insights for Investors - TipRanks
Over 31,000 Investors Are Getting Payouts from Novavax — Check What You Might Be Missing - TradingView
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine - MSN
Why Novavax Inc. stock attracts strong analyst attentionSolid Return Trade Selections - beatles.ru
Novavax (NVAX) Rises Higher Than Market: Key Facts - Yahoo Finance
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance
Novavax's Dual Vaccine Strategy: Navigating Near-Term Hurdles to Long-Term Growth Potential - AInvest
Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth (NASDAQ:NVAX) - Seeking Alpha
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet - Yahoo Finance
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors with Substantial Losses to Contact the Firm - ACCESS Newswire
(NVAX) Technical Data - news.stocktradersdaily.com
Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - MSN
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks - Benzinga
Novavax (NVAX) Dips More Than Broader Market: What You Should Know - Yahoo Finance
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval - Benzinga
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? - Yahoo Finance
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):